What BMI Do You Need to Qualify for GLP-1 Weight-Loss Telehealth?
The FDA's own approval label sets a real baseline: BMI 30, or BMI 27 with a weight-related condition. But that number is where the conversation starts, not where it ends — and BMI itself has real, acknowledged limits worth knowing before you fill out an intake form.
Our Sesame Care, NewSelf & TrimRx investigation compares what each company discloses about pricing, guarantees, and process — all three walk you through an online evaluation before a prescription is written. This is the question that usually comes first, before any of that: will you actually qualify in the first place?
The FDA baseline, in plain terms
Semaglutide and tirzepatide's weight-management indications (Wegovy and Zepbound) were approved by the FDA for a specific population, defined by body mass index:
- BMI of 30 or higher on its own — classified as obesity.
- BMI of 27 to 29.9 — classified as overweight — qualifies if paired with at least one weight-related health condition, such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea.
- Below a BMI of 27 generally falls outside the FDA-approved population for weight-loss use, regardless of comorbidities.
Sesame Care publishes this criterion directly. Reviewing Sesame Care's own published eligibility information, the company states the same FDA-aligned threshold — BMI 27 or higher with a qualifying weight-related condition (or 30+ on its own) — plus additional practical requirements: a commitment to ongoing nutrition and activity changes, and the ability to self-administer an injection at home with guidance. A licensed provider still reviews individual medical history and lab work before final approval.
NewSelf and TrimRx don't publish an equally specific numeric BMI cutoff in their own public marketing at the time of this writing — that's not necessarily a red flag on its own (many telehealth intake processes are designed to have a provider assess eligibility case-by-case after you complete a health questionnaire, rather than gating access with a number up front), but it does mean you should expect to actually complete their intake process, not assume eligibility either way from BMI alone.
Where telehealth providers can differ from the FDA label
The FDA label is a floor, not a fixed rule every provider follows identically. Some telehealth companies apply the label criteria exactly. Others set stricter internal thresholds — requiring a higher BMI, or requiring a documented comorbidity even above 30. And some prescribe GLP-1 medications off-label to patients below the FDA's threshold, a more clinically debated practice that a cautious, well-regulated provider will typically flag directly rather than treat as routine. Any of these choices reflects the provider's own clinical policy — not a universal rule — so the honest move is to check, not assume, before you commit time to an intake form.
What BMI doesn't capture — worth knowing either way
BMI is the standard eligibility metric because it's simple, well-studied at a population level, and required for FDA labeling purposes — not because it's a perfect individual measurement. Per the CDC and NIH, BMI is calculated from height and weight alone; it doesn't distinguish muscle mass from fat mass, doesn't account for where fat is distributed on the body (a factor that matters for metabolic risk), and can misclassify very muscular individuals as "overweight" despite low body fat. For most adults being screened for a weight-loss program, it's a reasonable starting proxy — but it's genuinely a proxy, not a direct measurement of metabolic health, which is part of why a real intake process includes more than a single number.
The real, FDA-anchored baseline is BMI 30 alone, or BMI 27–29.9 with a qualifying health condition. Sesame Care publishes this criterion directly; NewSelf and TrimRx evaluate through their own intake process rather than a published public number. Either way, a real provider reviews your actual health history before approving a prescription — treat the BMI threshold as the starting filter, not the final word, and expect a genuine medical evaluation, not just a self-reported number, before any of these three companies ships a prescription.
See how Sesame Care, NewSelf, and TrimRx actually differ on pricing, guarantees, and the fine print each one discloses before you sign up.
Read the full investigation →Sources
- Yale Medicine — "GLP-1 Medications for Weight Loss: How to Get Started"
- Sesame Care — Wegovy® prescription eligibility information (vendor's own page)
- U.S. Food & Drug Administration — Wegovy full prescribing information (approved population)
- CDC — About Body Mass Index (what BMI does and doesn't measure)
Not medical advice. Eligibility for any prescription weight-loss medication is a decision for a licensed provider based on your full health history, not a self-assessment from BMI alone. Questions about this piece? Email contact@healthyhealthsecrets.com. See also our About page and affiliate disclosure.